Clinical Study

The Effect of Depression on Serum VEGF Level in Alzheimer’s Disease

Table 1

Demographic and clinical characteristics of study subjects.

VariablesAD + depression
()
AD − depression
()
Control
()
Statistics
VariablesMean ± SDMean ± SD

Sex (M/F)4/205/2011/15 0.080
Age77.00 ± 8.0276.88 ± 5.5674.08 ± 4.150.158
Hypertension (%)14 (58.33%)16 (64%)9 (34.62%)0.083
BMI22.59 ± 2.5621.93 ± 2.7423.34 ± 3.040.200
Smoking4 (16.67%)2 (8%)1 (3.85%)0.286
SGDS-K9.96 ± 3.582.50 ± 2.580.58 ± 0.860.000
MMSE-KC15.88 ± 3.5814.72 ± 3.7127.77 ± 1.630.000
CDR0.96 ± 0.391.08 ± 0.690 ± 00.452

Analysis of variance was used to determine the value compared to the control. Note. AD + depression, Alzheimer’s disease with depression; AD − depression, Alzheimer’s disease without depression; Control, normal control; SD, standard deviation; BMI, body mass index; MMSE-KC, Mini-Mental State Examination-Korean version; SGDS-K, Korean version of the Geriatric Depression Scale-Short Form; CDR, Clinical Dementia Rating scale.